These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 38820975)

  • 1. Surface engineered multifunctional nano-systems for localised drug delivery against thyroid cancer: A review of current practices.
    Zhang Y; Tang N; Zhou H; Zhu Y
    Biomed Pharmacother; 2024 Jul; 176():116840. PubMed ID: 38820975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-therapeutics: The upcoming nanomedicine to treat cancer.
    Khan H; Shahab U; Alshammari A; Alyahyawi AR; Akasha R; Alharazi T; Ahmad R; Khanam A; Habib S; Kaur K; Ahmad S; Moinuddin
    IUBMB Life; 2024 Aug; 76(8):468-484. PubMed ID: 38440959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Application of Nanotechnology for the Diagnosis and Treatment of Endocrine Disorders: A Review of Current Trends, Toxicology and Future Perspective.
    Yan Y; Cai H; Yang M
    Int J Nanomedicine; 2024; 19():9921-9942. PubMed ID: 39345911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements.
    Liu L; Yang M; Chen Z
    Drug Deliv; 2024 Dec; 31(1):2390022. PubMed ID: 39138394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-based drug delivery system for therapeutics: a comprehensive review.
    Prakash S
    Biomed Phys Eng Express; 2023 Aug; 9(5):. PubMed ID: 37549657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
    Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
    Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies - Spotlight on prostate and colorectal cancer.
    Yang G; Cao Y; Yang X; Cui T; Tan NZV; Lim YK; Fu Y; Cao X; Bhandari A; Enikeev M; Efetov S; Balaban V; He M
    Exp Mol Pathol; 2024 Jun; 137():104904. PubMed ID: 38788248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicines in Diagnosis and Treatment of Cancer: An Update.
    Haider N; Fatima S; Taha M; Rizwanullah M; Firdous J; Ahmad R; Mazhar F; Khan MA
    Curr Pharm Des; 2020; 26(11):1216-1231. PubMed ID: 32188379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
    Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
    Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-engineering nanomedicines with customized functions for tumor treatment applications.
    Wang Y; Li S; Ren X; Yu S; Meng X
    J Nanobiotechnology; 2023 Aug; 21(1):250. PubMed ID: 37533106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma.
    Arshad R; Barani M; Rahdar A; Sargazi S; Cucchiarini M; Pandey S; Kang M
    Biosensors (Basel); 2021 Mar; 11(4):. PubMed ID: 33810621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
    Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
    AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.
    Jia F; Liu X; Li L; Mallapragada S; Narasimhan B; Wang Q
    J Control Release; 2013 Dec; 172(3):1020-34. PubMed ID: 24140748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.